AGL(agilon health, inc.) · 财务报表

AGL(agilon health, inc.) 的财务报表:医疗保健,医疗机构。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$1.52B$2.39B$4.32B$6.06B$5.93B
毛利润—————
营业利润−$372.24M−$105.38M−$232.13M−$292.13M−$463.24M
净利润−$406.49M−$106.55M−$262.60M−$260.15M−$391.35M
经营现金流−$148.16M−$130.81M−$156.20M−$57.78M−$105.76M
自由现金流−$154.72M−$146.23M−$172.03M−$71.03M−$119.00M
摊薄每股收益—————

agilon health, inc. AGL